Clinical Trial Update: Randomized Trial of Erythropoietin During Cerebral Malaria [Phase 2, Phase 3]

View source ↗

Summary

An update on a randomized trial evaluating erythropoietin for cerebral malaria across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Malaria

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Claude Bernard University | Conditions: Cerebral Malaria | Phase 2, Phase 3 | Status: UNKNOWN